Avantax Planning Partners’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Avantax Planning Partners’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$4K	–	391
2022 Q4	$4K	Buy	+10,000	New	+$6.49K	﹤0.01%	366

Avantax Planning Partners's AYLA Position: Q1 2023 in Review

Avantax Planning Partners sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q1 2023, closing a stake of 10,000 shares — an estimated $4K sold.

Avantax Planning Partners first reported a position in AYLA in Q4 2022 and held it in 1 quarter. The position peaked at $4K in Q4 2022. 0 funds tracked by Wall St. Rank hold AYLA as of Q1 2023.

Avantax Planning Partners reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Avantax Planning Partners sold 10,000 Ayala Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $4K.
Avantax Planning Partners first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Avantax Planning Partners's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $4K in Q4 2022.
0 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Avantax Planning Partners's 13F filing for Q1 2023, filed 21 Apr 2023.